Copyright Reports & Markets. All rights reserved.

Global Fumonisin B1 Market Outlook 2021

Request for Sample of this report
Buy now

1 Fumonisin B1 Market Overview

  • 1.1 Product Overview and Scope of Fumonisin B1
  • 1.2 Fumonisin B1 Segment by Type
    • 1.2.1 Global Fumonisin B1 Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 Min Purity Less Than 98%
    • 1.2.3 Min Purity 98%-99%
    • 1.2.4 Min Purity More Than 99%
  • 1.3 Fumonisin B1 Segment by Application
    • 1.3.1 Fumonisin B1 Sales Comparison by Application: (2020-2026)
    • 1.3.2 Research
    • 1.3.3 Medical
  • 1.4 Global Fumonisin B1 Market Size Estimates and Forecasts
    • 1.4.1 Global Fumonisin B1 Revenue 2015-2026
    • 1.4.2 Global Fumonisin B1 Sales 2015-2026
    • 1.4.3 Fumonisin B1 Market Size by Region: 2020 Versus 2026

2 Global Fumonisin B1 Market Competition by Manufacturers

  • 2.1 Global Fumonisin B1 Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Fumonisin B1 Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Fumonisin B1 Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Fumonisin B1 Manufacturing Sites, Area Served, Product Type
  • 2.5 Fumonisin B1 Market Competitive Situation and Trends
    • 2.5.1 Fumonisin B1 Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Fumonisin B1 Players (Opinion Leaders)

3 Fumonisin B1 Retrospective Market Scenario by Region

  • 3.1 Global Fumonisin B1 Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Fumonisin B1 Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Fumonisin B1 Market Facts & Figures by Country
    • 3.3.1 North America Fumonisin B1 Sales by Country
    • 3.3.2 North America Fumonisin B1 Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Fumonisin B1 Market Facts & Figures by Country
    • 3.4.1 Europe Fumonisin B1 Sales by Country
    • 3.4.2 Europe Fumonisin B1 Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Fumonisin B1 Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Fumonisin B1 Sales by Region
    • 3.5.2 Asia Pacific Fumonisin B1 Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Fumonisin B1 Market Facts & Figures by Country
    • 3.6.1 Latin America Fumonisin B1 Sales by Country
    • 3.6.2 Latin America Fumonisin B1 Sales by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Fumonisin B1 Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Fumonisin B1 Sales by Country
    • 3.7.2 Middle East and Africa Fumonisin B1 Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Fumonisin B1 Historic Market Analysis by Type

  • 4.1 Global Fumonisin B1 Sales Market Share by Type (2015-2020)
  • 4.2 Global Fumonisin B1 Revenue Market Share by Type (2015-2020)
  • 4.3 Global Fumonisin B1 Price Market Share by Type (2015-2020)
  • 4.4 Global Fumonisin B1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Fumonisin B1 Historic Market Analysis by Application

  • 5.1 Global Fumonisin B1 Sales Market Share by Application (2015-2020)
  • 5.2 Global Fumonisin B1 Revenue Market Share by Application (2015-2020)
  • 5.3 Global Fumonisin B1 Price by Application (2015-2020)

6 Company Profiles and Key Figures in Fumonisin B1 Business

  • 6.1 Adooq Bioscience
    • 6.1.1 Corporation Information
    • 6.1.2 Adooq Bioscience Description, Business Overview
    • 6.1.3 Adooq Bioscience Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 Adooq Bioscience Products Offered
    • 6.1.5 Adooq Bioscience Recent Development
  • 6.2 LKT Laboratories
    • 6.2.1 LKT Laboratories Corporation Information
    • 6.2.2 LKT Laboratories Description, Business Overview
    • 6.2.3 LKT Laboratories Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 LKT Laboratories Products Offered
    • 6.2.5 LKT Laboratories Recent Development
  • 6.3 Abcam
    • 6.3.1 Abcam Corporation Information
    • 6.3.2 Abcam Description, Business Overview
    • 6.3.3 Abcam Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Abcam Products Offered
    • 6.3.5 Abcam Recent Development
  • 6.4 Spectrum Chemical
    • 6.4.1 Spectrum Chemical Corporation Information
    • 6.4.2 Spectrum Chemical Description, Business Overview
    • 6.4.3 Spectrum Chemical Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Spectrum Chemical Products Offered
    • 6.4.5 Spectrum Chemical Recent Development
  • 6.5 StressMarq Biosciences
    • 6.5.1 StressMarq Biosciences Corporation Information
    • 6.5.2 StressMarq Biosciences Description, Business Overview
    • 6.5.3 StressMarq Biosciences Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 StressMarq Biosciences Products Offered
    • 6.5.5 StressMarq Biosciences Recent Development
  • 6.6 Biosynth Carbosynth
    • 6.6.1 Biosynth Carbosynth Corporation Information
    • 6.6.2 Biosynth Carbosynth Description, Business Overview
    • 6.6.3 Biosynth Carbosynth Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 Biosynth Carbosynth Products Offered
    • 6.6.5 Biosynth Carbosynth Recent Development
  • 6.7 LGC
    • 6.6.1 LGC Corporation Information
    • 6.6.2 LGC Description, Business Overview
    • 6.6.3 LGC Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 LGC Products Offered
    • 6.7.5 LGC Recent Development
  • 6.8 Cayman Chemical
    • 6.8.1 Cayman Chemical Corporation Information
    • 6.8.2 Cayman Chemical Description, Business Overview
    • 6.8.3 Cayman Chemical Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.8.4 Cayman Chemical Products Offered
    • 6.8.5 Cayman Chemical Recent Development
  • 6.9 Santa Cruz Biotechnology
    • 6.9.1 Santa Cruz Biotechnology Corporation Information
    • 6.9.2 Santa Cruz Biotechnology Description, Business Overview
    • 6.9.3 Santa Cruz Biotechnology Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.9.4 Santa Cruz Biotechnology Products Offered
    • 6.9.5 Santa Cruz Biotechnology Recent Development
  • 6.10 Bio-Techne
    • 6.10.1 Bio-Techne Corporation Information
    • 6.10.2 Bio-Techne Description, Business Overview
    • 6.10.3 Bio-Techne Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.10.4 Bio-Techne Products Offered
    • 6.10.5 Bio-Techne Recent Development
  • 6.11 Merck
    • 6.11.1 Merck Corporation Information
    • 6.11.2 Merck Fumonisin B1 Description, Business Overview
    • 6.11.3 Merck Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.11.4 Merck Products Offered
    • 6.11.5 Merck Recent Development
  • 6.12 Enzo Biochem
    • 6.12.1 Enzo Biochem Corporation Information
    • 6.12.2 Enzo Biochem Fumonisin B1 Description, Business Overview
    • 6.12.3 Enzo Biochem Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.12.4 Enzo Biochem Products Offered
    • 6.12.5 Enzo Biochem Recent Development
  • 6.13 Focus Biomolecules
    • 6.13.1 Focus Biomolecules Corporation Information
    • 6.13.2 Focus Biomolecules Fumonisin B1 Description, Business Overview
    • 6.13.3 Focus Biomolecules Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.13.4 Focus Biomolecules Products Offered
    • 6.13.5 Focus Biomolecules Recent Development
  • 6.14 STEMCELL Technologies
    • 6.14.1 STEMCELL Technologies Corporation Information
    • 6.14.2 STEMCELL Technologies Fumonisin B1 Description, Business Overview
    • 6.14.3 STEMCELL Technologies Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.14.4 STEMCELL Technologies Products Offered
    • 6.14.5 STEMCELL Technologies Recent Development
  • 6.15 APExBIO Technology
    • 6.15.1 APExBIO Technology Corporation Information
    • 6.15.2 APExBIO Technology Fumonisin B1 Description, Business Overview
    • 6.15.3 APExBIO Technology Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.15.4 APExBIO Technology Products Offered
    • 6.15.5 APExBIO Technology Recent Development
  • 6.16 Pharmaffiliates
    • 6.16.1 Pharmaffiliates Corporation Information
    • 6.16.2 Pharmaffiliates Fumonisin B1 Description, Business Overview
    • 6.16.3 Pharmaffiliates Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.16.4 Pharmaffiliates Products Offered
    • 6.16.5 Pharmaffiliates Recent Development
  • 6.17 Cato Research Chemicals
    • 6.17.1 Cato Research Chemicals Corporation Information
    • 6.17.2 Cato Research Chemicals Fumonisin B1 Description, Business Overview
    • 6.17.3 Cato Research Chemicals Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.17.4 Cato Research Chemicals Products Offered
    • 6.17.5 Cato Research Chemicals Recent Development
  • 6.18 Aladdin
    • 6.18.1 Aladdin Corporation Information
    • 6.18.2 Aladdin Fumonisin B1 Description, Business Overview
    • 6.18.3 Aladdin Fumonisin B1 Sales, Revenue and Gross Margin (2015-2020)
    • 6.18.4 Aladdin Products Offered
    • 6.18.5 Aladdin Recent Development

7 Fumonisin B1 Manufacturing Cost Analysis

  • 7.1 Fumonisin B1 Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Fumonisin B1
  • 7.4 Fumonisin B1 Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Fumonisin B1 Distributors List
  • 8.3 Fumonisin B1 Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Fumonisin B1 Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Fumonisin B1 by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Fumonisin B1 by Type (2021-2026)
  • 10.2 Fumonisin B1 Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Fumonisin B1 by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Fumonisin B1 by Application (2021-2026)
  • 10.3 Fumonisin B1 Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Fumonisin B1 by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Fumonisin B1 by Region (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type, the Fumonisin B1 market is segmented into
    Min Purity Less Than 98%
    Min Purity 98%-99%
    Min Purity More Than 99%

    Segment by Application
    Research
    Medical

    Global Fumonisin B1 Market: Regional Analysis
    The Fumonisin B1 market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Fumonisin B1 market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Global Fumonisin B1 Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Fumonisin B1 market include:
    Adooq Bioscience
    LKT Laboratories
    Abcam
    Spectrum Chemical
    StressMarq Biosciences
    Biosynth Carbosynth
    LGC
    Cayman Chemical
    Santa Cruz Biotechnology
    Bio-Techne
    Merck
    Enzo Biochem
    Focus Biomolecules
    STEMCELL Technologies
    APExBIO Technology
    Pharmaffiliates
    Cato Research Chemicals
    Aladdin

    Buy now